Ontology highlight
ABSTRACT:
SUBMITTER: Williams J
PROVIDER: S-EPMC4301301 | biostudies-literature | 2013
REPOSITORIES: biostudies-literature
Williams Jarrod J Spitnale Michael M Lodder Robert R
Journal of developing drugs 20130101
D-tagatose is in development as a medication for the treatment of type 2 diabetes. The effect of oral D-tagatose on the absorption of D-fructose was assessed when co-administered in this study. In the pilot study, male Sprague-Dawley rats were fed C14 labeled fructose and glucose concomitantly to establish dose levels for the treatment group of rats fed C14 labeled fructose together with D-tagatose. Rats were administered 0, 600, 2000, 6000, or 12000 mg/kg of D-tagatose along with 2000 mg/kg of ...[more]